A detailed history of Reynders Mc Veigh Capital Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Reynders Mc Veigh Capital Management, LLC holds 5,613 shares of DXCM stock, worth $445,391. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,613
Previous 8,115 30.83%
Holding current value
$445,391
Previous $920,000 59.13%
% of portfolio
0.02%
Previous 0.05%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$64.0 - $116.06 $160,128 - $290,382
-2,502 Reduced 30.83%
5,613 $376,000
Q2 2024

Aug 13, 2024

SELL
$110.31 - $140.45 $41,917 - $53,370
-380 Reduced 4.47%
8,115 $920,000
Q1 2024

May 07, 2024

SELL
$114.22 - $140.1 $354,082 - $434,310
-3,100 Reduced 26.74%
8,495 $1.18 Million
Q4 2023

Feb 07, 2024

SELL
$75.49 - $124.16 $573,573 - $943,367
-7,598 Reduced 39.59%
11,595 $1.44 Million
Q3 2023

Nov 09, 2023

SELL
$86.06 - $137.93 $264,634 - $424,134
-3,075 Reduced 13.81%
19,193 $1.79 Million
Q2 2023

Aug 09, 2023

SELL
$112.47 - $130.98 $116,631 - $135,826
-1,037 Reduced 4.45%
22,268 $2.86 Million
Q1 2023

May 03, 2023

SELL
$104.0 - $122.92 $129,792 - $153,404
-1,248 Reduced 5.08%
23,305 $2.71 Million
Q4 2022

Feb 10, 2023

SELL
$84.98 - $122.67 $53,962 - $77,895
-635 Reduced 2.52%
24,553 $2.78 Million
Q3 2022

Nov 08, 2022

SELL
$76.35 - $94.18 $91,620 - $113,016
-1,200 Reduced 4.55%
25,188 $2.03 Million
Q2 2022

Aug 05, 2022

BUY
$67.99 - $132.89 $1.34 Million - $2.63 Million
19,771 Added 298.79%
26,388 $1.97 Million
Q1 2022

May 11, 2022

SELL
$94.08 - $130.2 $29,635 - $41,013
-315 Reduced 4.54%
6,617 $3.39 Million
Q4 2021

Feb 11, 2022

SELL
$129.87 - $162.82 $78,571 - $98,506
-605 Reduced 8.03%
6,932 $3.72 Million
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $1,067 - $1,431
-10 Reduced 0.13%
7,537 $4.12 Million
Q2 2021

Aug 12, 2021

SELL
$80.99 - $107.93 $2,105 - $2,806
-26 Reduced 0.34%
7,547 $3.22 Million
Q1 2021

May 07, 2021

SELL
$84.79 - $104.74 $41,462 - $51,217
-489 Reduced 6.07%
7,573 $2.72 Million
Q4 2020

Feb 10, 2021

SELL
$78.0 - $104.5 $55,068 - $73,777
-706 Reduced 8.05%
8,062 $2.98 Million
Q3 2020

Oct 28, 2020

BUY
$95.51 - $112.95 $17,382 - $20,556
182 Added 2.12%
8,768 $3.61 Million
Q2 2020

Aug 14, 2020

SELL
$62.68 - $105.34 $80,418 - $135,151
-1,283 Reduced 13.0%
8,586 $3.48 Million
Q1 2020

May 13, 2020

SELL
$47.79 - $75.63 $29,773 - $47,117
-623 Reduced 5.94%
9,869 $2.66 Million
Q4 2019

Feb 14, 2020

SELL
$36.62 - $57.29 $6,701 - $10,484
-183 Reduced 1.71%
10,492 $2.3 Million
Q3 2019

Nov 08, 2019

BUY
$35.53 - $43.8 $4,085 - $5,037
115 Added 1.09%
10,675 $1.59 Million
Q2 2019

Aug 06, 2019

SELL
$27.84 - $38.92 $10,022 - $14,011
-360 Reduced 3.3%
10,560 $1.58 Million
Q2 2018

Aug 09, 2018

SELL
$17.54 - $25.22 $1,227 - $1,765
-70 Reduced 0.64%
10,920 $1.04 Million
Q1 2018

Jul 26, 2018

BUY
$13.06 - $18.54 $132,885 - $188,644
10,175 Added 1248.47%
10,990 $815,000
Q1 2018

May 03, 2018

SELL
$13.06 - $18.54 $134,518 - $190,962
-10,300 Reduced 92.67%
815 $11 Million
Q4 2017

Feb 06, 2018

BUY
$11.12 - $15.38 $123,598 - $170,948
11,115
11,115 $0

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Reynders Mc Veigh Capital Management, LLC Portfolio

Follow Reynders Mc Veigh Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.